Impact of the global COVID-19 outbreak on the management of other communicable diseases

Ong, Chee Wui; Goletti, Delia

doi:10.5588/ijtld.20.0140

Cited by 27 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a growing concern about the potentially negative impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of other infectious diseases [ [1] , [2] , [3] ]. Our study suggests that the risk of developing HAIE may increase during an outbreak of coronavirus infection.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Hospital-acquired infective endocarditis during Covid-19 pandemic

Ramos‐Martínez

Domínguez

Forteza

et al. 2020

Infection Prevention in Practice

View full text Add to dashboard Cite

Background The COVID pandemic has had a major impact on healthcare in hospitals, including the diagnosis and treatment of infections. Hospital-acquired infective endocarditis (HAIE) is a severe complication of medical procedures that has shown a progressive increase in recent years. Objectives To determine whether the incidence of HAIE during the first two months of the epidemic (March–April 2020) was higher than previously observed and to describe the clinical characteristics of these cases. The probability of the studied event (HAIE) during the study period was calculated by Poisson distribution. Results Four cases of HAIE were diagnosed in our institution during the study period. The incidence of HAIE during the study period was 2/patient-month and 0.3/patient-month during the same calender months in the previous 5 years (p=0.033). Two cases presented during admission for COVID-19 with pulmonary involvement treated with methylprednisolone and tocilizumab. The other two cases were admitted to the hospital during the epidemic. All cases underwent central venous and urinary catheterization during admission. The etiology of HAIE was Enterococcus faecalis (2 cases), Staphylococcus aureus and Candida albicans (one case each). A source of infection was identified in three cases (central venous catheter, peripheral venous catheter, sternal wound infection, respectively). One patient was operated on. Two patients died during hospital admission. Conclusions The incidence of HAIE during COVID-19 pandemic in our institution was higher than usual. In order to reduce the risk of this serious infection, optimal catheter care and early treatment of every local infection should be prioritized during coronavirus outbreaks.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The COVID pandemic has had a major impact on healthcare in hospitals, including the diagnosis and treatment of infections [ [1] , [2] , [3] ]. In order to reduce the spread of SARS-Cov-2 to patients and hospital staff, priority has been given to the care of life-threatening diseases over non-urgent conditions.…”

Section: Introductionmentioning

confidence: 99%

Hospital-acquired infective endocarditis during Covid-19 pandemic

Ramos‐Martínez

Domínguez

Forteza

et al. 2020

Infection Prevention in Practice

View full text Add to dashboard Cite

show abstract

“…Lastly, one TB patient developed SARS co-infection because of a wrong admission to a cohort of SARS patients [ 130 ]. This highlights the importance of remaining vigilant to other communicable diseases, including TB, when epidemic or pandemic infections dominate media headlines [ 131 ]. TB with MERS-CoV co-infection is also rare.…”

Section: Tb and Respiratory Viral Diseasesmentioning

confidence: 99%

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

et al. 2020

View full text Add to dashboard Cite

Major epidemics including some that qualify as pandemics, such as Severe Acute Respiratory Syndrome (SARS), Middle-Eastern Respiratory Syndrome (MERS), Human Immunodeficiency Virus, pandemic H1N1/09 and most recently COVID-19 affect the lung. Tuberculosis (TB) remains the top infectious disease killer but apart from the TB-HIV syndemic, little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of the viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN) and members of ESCMID Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors, excluding the ECDC PHE team identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology, immunology of these viral infections and their interactions with TB are discussed with implications on diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.

show abstract

“…Initial signs and symptoms of this highly infectious disease are similar to other respiratory infections such as TB [3], but clinical course and treatment differ among them with a higher mortality rate of COVID-19.…”

Section: Discussionmentioning

confidence: 91%

Concurrent cavitary pulmonary tuberculosisand COVID-19 pneumonia with in vitro immune cell anergy:a case report.

Musso

Gennaro

Gualano

et al. 2020

Preprint

View full text Add to dashboard Cite

Tuberculosis (TB) is top infectious disease killer caused by a single organismresponsible for 1.5 million deaths in 2018. Both COVID 19 and the pandemic responseare risking to affect control measures for TB and continuity of essential services forpeople affected by this infection in western countries and even more in developingcountries. Knowledges about concomitant pulmonary TB and COVID-19 are extremelylimited. The double burden of these two diseases can have devastating effects. Herewe describe from both the clinical and the immunological point of view a case of apatient with in vitro immune cell anergy affected by bilateral cavitary pulmonary TB andsubsequent COVID-19-associated pneumonia with a worst outcome. COVID-19 can bea precipitating factor in TB respiratory failure and, during ongoing SARS COV 2 pandemic, clinicians must be aware of this possible coinfection in differential diagnosisof patients with active TB and new or worsening chest imaging

show abstract

Impact of the global COVID-19 outbreak on the management of other communicable diseases

Cited by 27 publications

References 0 publications

Hospital-acquired infective endocarditis during Covid-19 pandemic

Hospital-acquired infective endocarditis during Covid-19 pandemic

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

Concurrent cavitary pulmonary tuberculosisand COVID-19 pneumonia with in vitro immune cell anergy:a case report.

Contact Info

Product

Resources

About